Template:Typhoid Antibiotics: Difference between revisions

Latest revision as of 17:26, 12 September 2014

if nalidixic acid resistant, assume fluoroquinolone resistant

OR

@@ Line 1: / Line 1: @@
-'''Oral therapy with Quinolone Susceptibility:'''
+====Oral therapy with [[Quinolone]] Susceptibility====
-*Ciprofloxacin 500-750 mg PO q 12 hrs x 14 days
+*[[Ciprofloxacin]] 500-750 mg PO q 12 hrs x 14 days
-'''Parenteral Therapy with Quinolone Susceptibility: '''
+====Parenteral Therapy with [[Quinolone]] Susceptibility====
-*Ciprofloxacin 400 mg IV q 12 hrs x 10 days
+*[[Ciprofloxacin]] 400 mg IV q 12 hrs x 10 days
-'''Parenteral Therapy with Quinolone Resistance:'''
+====Parenteral Therapy with [[Quinolone]] Resistance====
+:''if nalidixic acid resistant, assume [[fluoroquinolone]] resistant''
+*[[Ceftriaxone]] 2mg IV q 24 hrs x 14 days
+::'''OR'''
+*[[Cefixime]] 10-15 mg/kg IV q 12 hrs x 8 days
-:''if nalidixic acid resistant, assume fluoroquinolone resistant''
+====Oral Therapy with [[Quinolone]] Resistance====
-*Ceftriaxone 2mg IV q 24 hrs x 14 days
+*[[Azithromycin]] 1 g PO daily x 5 days
-::'''OR'''
-*Cefixime 10-15 mg/kg IV q 12 hrs x 8 days
-'''Oral Therapy with Quinolone Resistance:'''
-*Azithromycin 1 g PO daily x 5 days